昱霖陈
赞了
我们生活在对病毒的阴影/恐惧中将近两年。当我们以为自己差点征服它的时候。它像 Megaton 一样变成了另一种突变/变体。
在此期间,许多经验丰富的交易者认为他们的投资组合受到了Covid的感染并遭受了挫折。
而新交易者则认为他们的投资组合正处于 “接种疫苗” 的旅程中 🚀🌛。但是,对于一些新手来说,登月之旅可能会以爆炸告终。当他们意识到这一点时,他们起火了 🔥 🔥 🔥。
向前迈进,作为散户交易者,我们可能永远看不到未来的几个月了。也许 Mega Storm 潜伏在不远的将来。但是我们能做的就是把我们的产品 🍗🍗(投资)交给市场之神。为了取悦市场之神带领我们走向繁荣,将做出一些牺牲 👰♂️(损失)💰💰(上升趋势)
Huat Ah 2022 发型发型 🚀🚀🌛🌛
$特斯拉 (TSLA.US)$
$苹果 (AAPL.US)$
$SNDL Inc (SNDL.US)$
$AMC院线 (AMC.US)$
$Palantir (PLTR.US)$
$云顶新加坡 (G13.SG)$
$Lucid Group (LCID.US)$
$新加坡航空公司 (C6L.SG)$
$富途控股 (FUTU.US)$
$向上融科 (TIGR.US)$
$Camber Energy (CEI.US)$
$小鹏汽车 (XPEV.US)$
$蔚来 (NIO.US)$
$阿里巴巴 (BABA.US)$
$辉瑞 (PFE.US)$
$Grab Holdings (GRAB.US)$
$黑莓 (BB.US)$
$Moderna (MRNA.US)$
$新电信 (Z74.SG)$
在此期间,许多经验丰富的交易者认为他们的投资组合受到了Covid的感染并遭受了挫折。
而新交易者则认为他们的投资组合正处于 “接种疫苗” 的旅程中 🚀🌛。但是,对于一些新手来说,登月之旅可能会以爆炸告终。当他们意识到这一点时,他们起火了 🔥 🔥 🔥。
向前迈进,作为散户交易者,我们可能永远看不到未来的几个月了。也许 Mega Storm 潜伏在不远的将来。但是我们能做的就是把我们的产品 🍗🍗(投资)交给市场之神。为了取悦市场之神带领我们走向繁荣,将做出一些牺牲 👰♂️(损失)💰💰(上升趋势)
Huat Ah 2022 发型发型 🚀🚀🌛🌛
$特斯拉 (TSLA.US)$
$苹果 (AAPL.US)$
$SNDL Inc (SNDL.US)$
$AMC院线 (AMC.US)$
$Palantir (PLTR.US)$
$云顶新加坡 (G13.SG)$
$Lucid Group (LCID.US)$
$新加坡航空公司 (C6L.SG)$
$富途控股 (FUTU.US)$
$向上融科 (TIGR.US)$
$Camber Energy (CEI.US)$
$小鹏汽车 (XPEV.US)$
$蔚来 (NIO.US)$
$阿里巴巴 (BABA.US)$
$辉瑞 (PFE.US)$
$Grab Holdings (GRAB.US)$
$黑莓 (BB.US)$
$Moderna (MRNA.US)$
$新电信 (Z74.SG)$
已翻译
79
3
昱霖陈
赞了
$Block (SQ.US)$ 报税公司H&R Block Inc周四起诉支付公司Block Inc(前身为Square Inc),称新名称侵犯了其商标。
$福特汽车 (F.US)$ $英伟达 (NVDA.US)$ 由于半导体短缺,汽车制造商被迫在2020年和2021年减产,需求疲软,预计明年美国的新车销量将增加。埃德蒙兹预计,2022年汽车的销量将增加1,520万辆,尽管价格上涨,但仍增长了1.2%。
$福特汽车 (F.US)$ $英伟达 (NVDA.US)$ 由于半导体短缺,汽车制造商被迫在2020年和2021年减产,需求疲软,预计明年美国的新车销量将增加。埃德蒙兹预计,2022年汽车的销量将增加1,520万辆,尽管价格上涨,但仍增长了1.2%。
已翻译
18
昱霖陈
赞了
$辉瑞 (PFE.US)$ The Pfizer jab is "the hardest to deliver given ultra-cold chain and special syringe requirements", Gavi says in its internal document. It is also "the hardest to plan for as these (donated vaccines) often come with earmarking and little notice or in a staggered manner and in small volumes and with short shelf lives". Wealthy countries donating COVID-19 vaccines with a relatively short shelf life has been a "major problem" for COVAX, a WHO official said last week, as many doses were wasted.
7
昱霖陈
赞了
Shares of Biofrontera Inc. (BFRI) $Biofrontera (BFRI.US)$ are rising more than 13% in the morning trade on Monday.
Today, the company said that the first patient has been enrolled in the Phase 2 study to evaluate the safety and efficacy of the company's FDA approved product, Ameluz in combination with BF-RhodoLED for the treatment of moderate-to-severe acne with photodynamic therapy.
"This study is an important component of Biofrontera group's clinical development strategy that aims to expand the FDA-label of our licensed product Ameluz. The inclusion of additional indications aims at unlocking its full therapeutic and market potential in the US," stated Erica Monaco, Chief Executive Officer of Biofrontera Inc.
BFRI, currently at $6.08, has traded in the range of $2.25- $10.40 in the last one year.
Content is taken from Nasdaq.
Today, the company said that the first patient has been enrolled in the Phase 2 study to evaluate the safety and efficacy of the company's FDA approved product, Ameluz in combination with BF-RhodoLED for the treatment of moderate-to-severe acne with photodynamic therapy.
"This study is an important component of Biofrontera group's clinical development strategy that aims to expand the FDA-label of our licensed product Ameluz. The inclusion of additional indications aims at unlocking its full therapeutic and market potential in the US," stated Erica Monaco, Chief Executive Officer of Biofrontera Inc.
BFRI, currently at $6.08, has traded in the range of $2.25- $10.40 in the last one year.
Content is taken from Nasdaq.
8
昱霖陈
赞了
$Vir Biotechnology (VIR.US)$
几天前以 39.99 的价格进入现在要上涨了ppppp
几天前以 39.99 的价格进入现在要上涨了ppppp
已翻译
4